Cargando…

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

BACKGROUND: Development of targeted therapies for high-grade serous ovarian cancer (HGSC) remains challenging, as contributing molecular pathways are poorly defined or expressed heterogeneously. CUB-domain containing protein 1 (CDCP1) is a cell-surface protein elevated in lung, colorectal, pancreas,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrington, Brittney S, He, Yaowu, Davies, Claire M, Wallace, Sarah J, Adams, Mark N, Beaven, Elizabeth A, Roche, Deborah K, Kennedy, Catherine, Chetty, Naven P, Crandon, Alexander J, Flatley, Christopher, Oliveira, Niara B, Shannon, Catherine M, deFazio, Anna, Tinker, Anna V, Gilks, C Blake, Gabrielli, Brian, Brennan, Donal J, Coward, Jermaine I, Armes, Jane E, Perrin, Lewis C, Hooper, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Translational Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815773/ https://www.ncbi.nlm.nih.gov/pubmed/26882065 http://dx.doi.org/10.1038/bjc.2015.471

Ejemplares similares

New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways
por: He, Yaowu, et al.
Publicado: (2016)

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2020)

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021)

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
por: Khan, Tashbib, et al.
Publicado: (2020)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy
por: Khan, Tashbib, et al.
Publicado: (2022)

Vulvar yolk sac tumor diagnosed during pregnancy, with recurrence during subsequent second pregnancy
por: Xu, Wen, et al.
Publicado: (2015)

A review of experimental and computational attempts to remedy stability issues of perovskite solar cells
por: Kheralla, Adam, et al.
Publicado: (2021)

Radioprotective potential of Costus afer against the radiation-induced hematological and histopathological damage in mice
por: Akomolafe, Idowu Richard, et al.
Publicado: (2021)

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Low-cost fabrication of optical tissue phantoms for use in biomedical imaging
por: Ntombela, Lindokuhle, et al.
Publicado: (2020)

CDCP1 promotes compensatory renal growth by integrating Src and Met signaling
por: Kajiwara, Kentaro, et al.
Publicado: (2021)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery
por: Chay, Wen Yee, et al.
Publicado: (2015)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023)

CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells
por: Orchard-Webb, David J, et al.
Publicado: (2014)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease
por: Blanco, Jose-Ramon, et al.
Publicado: (2022)

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
por: Zhao, Jinlu, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein
por: Urabe, Fumihiko, et al.
Publicado: (2023)

CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis
por: Zhang, Lingjun, et al.
Publicado: (2022)

Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
por: Lim, Shion A., et al.
Publicado: (2022)

Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
por: Coward, Jermaine, et al.
Publicado: (2014)

CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production
por: Iwata, Mineo, et al.
Publicado: (2014)

Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012)

Novel small molecule inhibiting CDCP1‐PKCδ pathway reduces tumor metastasis and proliferation
por: Nakashima, Katsuhiko, et al.
Publicado: (2017)

The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma
por: Geng, Fei, et al.
Publicado: (2020)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
por: Forte, Luca, et al.
Publicado: (2018)

Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases
por: Magnusson, Louise, et al.
Publicado: (2020)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
por: Jia, Xi, et al.
Publicado: (2023)

Patterns of spread of clear cell ovarian cancer: Case report and case series()
por: Kumar, Aalok, et al.
Publicado: (2013)

New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_avtskgoeop9tcm6kb59km8p0cd